PHILADELPHIA - Aaron Temkin Beck, MD, the father of Cognitive Therapy, has been presented with the Anna-Monika Prize, awarded once every two years by the Anna-Monika Foundation, for advancing knowledge of the biological structure and functional disturbances of depression. The privately funded Anna-Monika Foundation, established in 1964 and based in Berlin, Germany, promotes experimental research on the causes of depression.
Dr. Beck was honored for his lifetime achievement in defining the cognitive biases and distorted interpretations of events, which represent the core psychological problem in depression and contribute to its symptoms, and using this knowledge to develop cognitive therapy. Professor F. A. Henn, Head of the Anna-Monika Prize Committee presented Dr. Beck with the award on Thursday, November 19, at the University of Pennsylvania’s Psychiatry Grand Rounds.
In 2006, Dr. Beck received the Albert Lasker Clinical Medical Research Award for developing cognitive therapy, which transformed the understanding and treatment of many psychiatric conditions, including depression, suicidal behavior, generalized anxiety, panic attacks, and eating disorders. He has been listed as one of the "10 individuals who shaped the face of American Psychiatry" and one of the 5 most influential psychotherapists of all time. He has published more than 550 scholarly articles and 18 books and has developed widely-used assessment scales.
Dr. Beck is an emeritus professor in the Department of Psychiatry at the University of Pennsylvania and the director of the Psychopathology Research Unit (PRU), which is the parent organization of the Center for the Treatment and Prevention of Suicide. His current research focuses on cognitive therapy for suicide prevention, dissemination of cognitive therapy into community settings, and cognitive therapy for schizophrenia.
Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $5.3 billion enterprise.
The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 18 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $373 million awarded in the 2015 fiscal year.
The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center -- which are recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report -- Chester County Hospital; Lancaster General Health; Penn Wissahickon Hospice; and Pennsylvania Hospital -- the nation's first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Chestnut Hill Hospital and Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2015, Penn Medicine provided $253.3 million to benefit our community.